LISATA THERAPEUTICS, INC.
Oncology firm with a platform for more effective, targeted delivery of anti-cancer drugs.
LSTA | NDAQ
Overview
Corporate Details
- ISIN(s):
- US1280583022 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 110 ALLEN ROAD, 7920 BASKING RIDGE
- Website:
- https://www.lisata.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company that discovers, develops, and commercializes innovative therapies for areas with high unmet medical needs. The company primarily focuses on oncology, developing treatments for advanced solid tumors and other serious diseases. Its core technology is the proprietary CendR Platform®, which is designed to enable more effective, tumor-targeted, and tissue-penetrating delivery of anti-cancer drugs. The platform also aims to target immunosuppressive cells within the tumor, potentially enhancing the efficacy of immunotherapies and the patient's own immune system in fighting cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all LISATA THERAPEUTICS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for LISATA THERAPEUTICS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for LISATA THERAPEUTICS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
